Vor Biopharma Inc. (VOR)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$371.64M | -$121.19M | -$126.04M | -$93.42M | -$69.02M | -$43.37M | — |
| Net Income | -$695.98M | -$116.91M | -$117.86M | -$92.09M | -$68.90M | -$43.34M | — |
| EPS (Diluted) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | — | — |
| Total Assets | $464.13M | $142.89M | $198.13M | $299.37M | $242.59M | $75.91M | — |
| Total Liabilities | $628.44M | $46.23M | $47.40M | $48.76M | $26.33M | $27.64M | — |
| Shareholders' Equity | -$164.31M | $96.66M | $150.72M | $250.61M | $216.26M | -$59.06M | -$17.43M |
| Cash & Equivalents | $396.49M | $81.95M | $31.36M | $57.71M | $119.80M | $48.54M | — |
| Operating Cash Flow | -$142.71M | -$99.66M | -$100.29M | -$85.14M | -$69.14M | -$36.29M | — |
| Capital Expenditures | $941.0K | $229.0K | $1.07M | $8.46M | $3.89M | $4.16M | — |
| Shares Outstanding | 38.72M | 6.24M | 67.89M | 66.00M | 37.17M | 505.1K | — |